![Jason A. Campagna](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jason A. Campagna
Directeur Technique/Scientifique/R&D chez Q32 Bio, Inc.
Fortune : - $ au 31/05/2024
Postes actifs de Jason A. Campagna
Sociétés | Poste | Début | Fin |
---|---|---|---|
Q32 Bio, Inc.
![]() Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Jason A. Campagna
Anciens postes connus de Jason A. Campagna
Sociétés | Poste | Début | Fin |
---|---|---|---|
PLANTABLE HEALTH INC. | Directeur/Membre du Conseil | 26/11/2021 | 31/03/2023 |
Independent Dir/Board Member | 26/11/2021 | 31/03/2023 | |
INTERCEPT PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/12/2019 | 05/03/2021 |
THE MEDICINES COMPANY | Corporate Officer/Principal | - | 01/08/2016 |
ProFibrix BV
![]() ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Directeur Général | - | - |
Annovation BioPharma, Inc.
![]() Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ. | Directeur/Membre du Conseil | - | - |
Formation de Jason A. Campagna
University of Miami | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Pays-Bas | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 6 |
Consumer Services | 2 |
Retail Trade | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
PLANTABLE HEALTH INC. | Retail Trade |
Entreprise privées | 4 |
---|---|
Annovation BioPharma, Inc.
![]() Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ. | Health Technology |
The Medicines Co.
![]() The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
ProFibrix BV
![]() ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Health Technology |
Q32 Bio, Inc.
![]() Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Jason A. Campagna
- Expérience